Groupama Asset Management’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.3M | Buy |
40,891
+7,439
| +22% | +$2.24M | 0.2% | 74 |
|
|
2025
Q1 | $11M | Buy |
33,452
+9,128
| +38% | +$2.99M | 0.22% | 73 |
|
|
2024
Q4 | $7.58M | Buy |
24,324
+11,487
| +89% | +$3.58M | 0.15% | 87 |
|
|
2024
Q3 | $2.19M | Buy |
12,837
+963
| +8% | +$164K | 0.06% | 169 |
|
|
2024
Q2 | $3.33M | Buy |
11,874
+11,659
| +5,423% | +$3.27M | 0.05% | 152 |
|
|
2024
Q1 | $3.02M | Sell |
215
-8,814
| -98% | -$124M | 0.06% | 185 |
|
|
2023
Q4 | $2.09M | Buy |
+9,029
| New | +$2.09M | 0.05% | 202 |
|